Loading...
Emerging targets for anticancer vaccination: IDH
The development of anticancer vaccines as a pillar of cancer immunotherapy has been hampered by the scarcity of suitable tumor-specific antigens. While response to immune checkpoint inhibitors is driven by T cells recognizing mutated antigens, the vast majority of these neoantigens are patient-speci...
Na minha lista:
| Udgivet i: | ESMO Open |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8287141/ https://ncbi.nlm.nih.gov/pubmed/34271312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100214 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|